Pharma
SPONSORED
HIMSS22 Europe
|
03:00 pm |
June 08, 2022
|
03:00 pm |
June 08, 2022
Governments, providers and patients have to be engaged and aligned to transform and digitize the entire continuum of care, according to Tamir Gotfried, chief commercial officer of Tytocare.
HIMSS22
Dr. Brian Anderson, Mitre's chief digital health physician, talks about the development of SMART Health Cards.
HIMSS22
Changemakers need to be on every team, according to Dr. Camila Murga, senior health informatician at Globant.
The companies said their long-term goal is to develop and offer more digital health tools "through a multi-partner ecosystem" as well as advocate for reimbursement options.
Under the deal, MedRhythms would receive a $3 million upfront payment and could earn up to $117.5 million if certain milestones are met.
The partnership, which includes Anthem, Biogen, Eli Lilly, Evidation, Janssen and Merck, gives payers guidance for including digital endpoints in reimbursement for new drugs.
Abbott's Jennifer Jones-McMeans outlines how finding community champions and creating digital tools can help boost diversity in clinical trials.
HIMSS22
UMPC's chief pharmacy officer Chronis Manolis discusses the future of pharmacies ahead of HIMSS22.
Germany’s Bayer has launched Saudi Arabia’s first “digital hub” to improve management of pulmonary hypertension (PH), it has announced.
The lab, which works with AstraZeneca, Merck, Pfizer, Israel Biotech Fund, Teva Pharmaceuticals, and Amazon Web Services, is currently accepting applicants for its new challenge.